FIM
MRNA icon

Freedom Investment Management’s Moderna MRNA Stock Holding History

Freedom Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14,759
Closed -$407K – 472
2025
Q2 		$407K Buy
14,759
+2,137
+17% +$56.3K 0.03% 505
2025
Q1 		$358K Buy
12,622
+4,551
+56% +$161K 0.03% 522
2024
Q4 		$336K Buy
8,071
+2,701
+50% +$129K 0.03% 556
2024
Q3 		$359K Sell
5,370
-1,232
-19% -$113K 0.03% 536
2024
Q2 		$784K Sell
6,602
-944
-13% -$119K 0.06% 299
2024
Q1 		$804K Sell
7,546
-1,066
-12% -$107K 0.06% 310
2023
Q4 		$856K Buy
8,612
+351
+4% +$29.5K 0.07% 295
2023
Q3 		$853K Sell
8,261
-944
-10% -$105K 0.1% 244
2023
Q2 		$1.12M Sell
9,205
-716
-7% -$95.5K 0.13% 212
2023
Q1 		$1.52M Sell
9,921
-63
-0.6% -$10.4K 0.17% 158
2022
Q4 		$1.79M Sell
9,984
-588
-6% -$96.1K 0.2% 124
2022
Q3 		$1.25M Sell
10,572
-124
-1% -$18.8K 0.14% 181
2022
Q2 		$1.53M Sell
10,696
-2,548
-19% -$364K 0.16% 165
2022
Q1 		$2.28M Sell
13,244
-3,219
-20% -$542K 0.2% 119
2021
Q4 		$4.18M Buy
16,463
+471
+3% +$138K 0.31% 68
2021
Q3 		$6.16M Sell
15,992
-11,589
-42% -$4.27M 0.47% 34
2021
Q2 		$6.48M Sell
27,581
-4,136
-13% -$739K 0.48% 36
2021
Q1 		$4.15M Buy
+31,717
New +$4.6M 0.32% 65

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Freedom Investment Management's MRNA Position: Q3 2025 in Review

Freedom Investment Management sold out of Moderna (MRNA) in Q3 2025, closing a stake of 14,759 shares — an estimated $407K sold.

Freedom Investment Management first reported a position in MRNA in Q1 2021 and held it in 18 quarters. The position peaked at $6.48M in Q2 2021. 643 funds tracked by Wall St. Rank hold MRNA as of Q3 2025.

  • Freedom Investment Management reported no remaining Moderna position as of Q3 2025 after selling out during the quarter.
  • Freedom Investment Management sold 14,759 Moderna shares in Q3 2025, an estimated $407K.
  • Freedom Investment Management first reported a position in Moderna in Q1 2021 and held it in 18 quarters.
  • Freedom Investment Management's Moderna position peaked at $6.48M in Q2 2021.
  • 643 funds tracked by Wall St. Rank held Moderna as of Q3 2025.

Based on Freedom Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.